Invention Grant
- Patent Title: Rapidly-orodispersible tablets having an in interior cavity
-
Application No.: US17513307Application Date: 2021-10-28
-
Publication No.: US11433022B2Publication Date: 2022-09-06
- Inventor: Jaedeok Yoo , Aleece M. Phillips , Thomas J. Bradbury , Thomas G. West
- Applicant: APRECIA PHARMACEUTICALS LLC
- Applicant Address: US OH Blue Ash
- Assignee: APRECIA PHARMACEUTICALS LLC
- Current Assignee: APRECIA PHARMACEUTICALS LLC
- Current Assignee Address: US OH Blue Ash
- Agency: Nesbitt IP LLC
- Agent Daniel F. Nesbitt
- Main IPC: A61K9/56
- IPC: A61K9/56 ; A61K9/00 ; A61K9/20

Abstract:
A rapidly-orodispersible dosage form comprising a porous, bound-powder matrix and one or more internal cavities is provided, as well as three-dimensional printing methods for making the same. Each internal cavity is configured to contain one or more payloads, particularly pharmaceutical medicaments, while isolating the payloads from the external environment outside of the dosage form. Each payload can be contained within its cavity in its native form without having to be combined with the bound-powder matrix or binding liquid. Dosage forms can disintegrate in water or saliva in less than two minutes, independently of the payload(s) or medicament(s) contained within. The dosage forms can be formed as unitary tablets, or as two-piece tablets comprising a container body and a lidding body that are secured together to isolate the one or more cavities and their payloads inside.
Public/Granted literature
- US20220054409A1 RAPIDLY-ORODISPERSIBLE TABLETS HAVING AN INTERIOR CAVITY Public/Granted day:2022-02-24
Information query